Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy - Trial NCT06406010
Access comprehensive clinical trial information for NCT06406010 through Pure Global AI's free database. This Phase 4 trial is sponsored by Matias Vested and is currently Not yet recruiting. The study focuses on Anesthesia, Local. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Matias Vested
Rigshospitalet, Denmark
Timeline & Enrollment
Phase 4
Jun 01, 2024
Jan 01, 2026
Primary Outcome
Pain during first 24 hours postoperatively
Summary
The aim of this study is to determine the effect of PENG blockade on postoperative pain after
 either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of
 this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo
 (saline).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06406010
Non-Device Trial